Jiangzhong Pharmaceutical Affiliate Posts 16.6% Operating Profit Growth for 2025
I'm PortAI, I can summarize articles.
China Resources Jiangzhong Pharmaceutical Co., Ltd. reported a 16.6% growth in operating profit for 2025, with total operating revenue of RMB 4.2195 billion and an operating profit of RMB 1.1985 billion. The net profit attributable to shareholders was RMB 906.12 million. Jiangzhong Pharmaceutical is a subsidiary of China Resources Pharmaceutical Group Ltd., which holds a 26.12% interest in the company. The financial information is based on unaudited preliminary results for the year ended December 31, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments